Weaning HFNC: When to Stop High-Flow Oxygen in Acute Respiratory Failure
Official title: Effect of High Flow Nasal Therapy (HFNC) Weaning Protocols vs Standard of Care on Respiratory Outcomes in Patients With Acute Respiratory Failure: A Randomized Clinical Trial
Run by University of Milan · NCT07638293 · Data updated 2026-11-12
This study tests a protocol to guide when to stop high-flow nasal therapy in adults with acute respiratory failure who are already on HFNC.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 148 (estimated) |
| Sponsor | University of Milan Academic / other |
| Locations | 2 sites (Milan, Lombardy and 1 other locations) |
| Status | Recruiting |
| Started | May 15, 2026 |
| Main results expected | May 2028 |
| Study ends | May 2028 |
| Registry record updated | June 10, 2026 |
| Trial ID | NCT07638293 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 and older with acute respiratory failure who have been on HFNC for at least 24 hours and do not have contraindications listed in the criteria.
✕Probably not a fit
Patients with post-extubation HFNC, significant hypercapnia, DNI orders, terminal non-respiratory illness, or other listed contraindications may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares a protocolized weaning approach for high-flow nasal therapy (HFNC) against standard care in adults with acute respiratory failure. It aims to reduce variability in HFNC discontinuation and identify criteria that predict safe weaning, such as FiO2 ≤ 40% and a ROX index ≥ 9.2. The protocol focuses on standardized steps to taper HFNC while monitoring for signs of deterioration. The trial will measure respiratory outcomes and resource use to determine if structured weaning improves patient care and efficiency.
Why it matters
Potential benefit: If successful, the protocol could standardize HFNC discontinuation, potentially shortening hospital stays and reducing resource use without increasing respiratory complications.
How similar studies have gone: Previous research suggests that using FiO2 and ROX index metrics can help predict successful HFNC weaning, though standardized protocols are not yet widely adopted.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * Presence of acute respiratory failure (ARF) * Receiving HFNC treatment for ≥24 hours Exclusion Criteria: * Post-extubation HFNC use or tracheostomized patients * Respiratory acidosis (pH \<7.35) or clinically significant acute hypercapnia (pCO₂ \>50 mmHg with worsening from baseline) * Long-term home NIV or home CPAP use * Do-not-intubate (DNI) orders precluding escalation to invasive mechanical ventilation * Life expectancy ≤48-72 hours due to terminal non-respiratory disease * Neurological impairment or deep sedation preventing safe HFNC use (e.g. coma or severe uncontrolled delirium) * Technical contraindications to HFNC (i.e. facial trauma, maxillofacial surgery, severe nasal obstruction) * Refusal to participate or inability to provide informed consent
Where it's running
-
Pulmonology Unit, ASST Santi Paolo e Carlo. Department of Health Sciences, University of Milan, Milan (Italy)
Milan, Lombardy, Italy Recruiting -
Pulmonology Unit, University Hospital "G. Rodolico-San Marco"
Catania, Sicily, Italy Not yet recruiting
Study contacts
- Study coordinator: Michele Mondoni, MD
- Email: michele.mondoni@unimi.it
- Phone: +39 0240223025
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Monitoring breathing muscle function in ARF patients on non-invasive support
This study tests whether advanced breathing-muscle monitoring can help care teams manage adults with acute respiratory failure who are on non-invasive respiratory support.
-
Comparing 3D/2D electrical impedance tomography and the R/I ratio to measure lung recruitability during mechanical ventilation
This test tries to see if two imaging methods (3D and 2D electrical impedance tomography) and a pressure-based recruitment-to-inflation (R/I) ratio give consistent estimates of how much the lungs can be recruited in sedated adults on mechanical ventilation for acute respiratory failure.
-
Bedside measurement of lung collapse and reopening in people on invasive mechanical ventilation
This project will try using ventilator-recorded pressure and volume data to measure how much lung tissue opens with inhalation and then collapses again with exhalation in people on passive invasive mechanical ventilation for acute respiratory failure.
-
Home oxygen with high-flow therapy vs standard oxygen for chronic lung and heart disease
In people with long-term lung or heart conditions who need oxygen after leaving the hospital, the study tests whether a high-flow nasal cannula (HFNC) can improve breathing comfort and quality of life compared with standard oxygen therapy.
-
Music therapy to ease pain during noninvasive ventilation in children
This trial will try using a structured music program to lower pain and improve comfort for children (0–17) who are starting noninvasive ventilation in the pediatric intensive care unit.
-
Assessing Diaphragm Activity and Breathing Mechanics During NAVA Ventilation
This study is testing if a special type of breathing support called NAVA can help lung transplant patients breathe better and protect their lungs while they recover in the ICU.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.